Pharmacovigilance in developing countries (part II): a path forward

12Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In recent years, attention to pharmacovigilance has gained momentum in developing countries, however awareness of, and policies or systems for pharmacovigilance in most developing countries still lags sharply behind developed countries. This article proposes different strategies to encourage the introduction and sustain the advancement of robust pharmacovigilance systems in developing countries. To this end, this article seeks to accomplish the ultimate goal of pharmacovigilance in a developing country context; ensuring patient safety and promoting safe and rational use of drugs.

Cite

CITATION STYLE

APA

Elshafie, S., Roberti, A. M., & Zaghloul, I. (2018). Pharmacovigilance in developing countries (part II): a path forward. International Journal of Clinical Pharmacy, 40(4), 764–768. https://doi.org/10.1007/s11096-017-0588-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free